Capstone Investment Advisors’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-13,100
| Closed | -$1.32M | – | 1619 |
|
|
2025
Q4 | $1.32M | Buy |
+13,100
| New | +$1.42M | ﹤0.01% | 759 |
|
|
2025
Q2 | – | Sell |
-2,000
| Closed | -$295K | – | 1609 |
|
|
2025
Q1 | $295K | Sell |
2,000
-5,100
| -72% | -$779K | ﹤0.01% | 1193 |
|
|
2024
Q4 | $1.15M | Buy |
7,100
+900
| +15% | +$147K | ﹤0.01% | 1022 |
|
|
2024
Q3 | $1.01M | Buy |
6,200
+600
| +11% | +$88.9K | ﹤0.01% | 956 |
|
|
2024
Q2 | $764K | Buy |
5,600
+600
| +12% | +$83.3K | ﹤0.01% | 1094 |
|
|
2024
Q1 | $766K | Sell |
5,000
-5,400
| -52% | -$806K | ﹤0.01% | 1304 |
|
|
2023
Q4 | $1.48M | Buy |
10,400
+3,600
| +53% | +$480K | ﹤0.01% | 900 |
|
|
2023
Q3 | $891K | Buy |
6,800
+1,100
| +19% | +$167K | ﹤0.01% | 1027 |
|
|
2023
Q2 | $907K | Buy |
5,700
+400
| +8% | +$64.5K | ﹤0.01% | 904 |
|
|
2023
Q1 | $839K | Buy |
5,300
+800
| +18% | +$120K | ﹤0.01% | 844 |
|
|
2022
Q4 | $631K | Buy |
4,500
+500
| +13% | +$71K | ﹤0.01% | 1060 |
|
|
2022
Q3 | $514K | Buy |
4,000
+300
| +8% | +$43.3K | ﹤0.01% | 1242 |
|
|
2022
Q2 | $522K | Sell |
3,700
-14,500
| -80% | -$2.07M | ﹤0.01% | 1221 |
|
|
2022
Q1 | $2.53M | Sell |
18,200
-15,700
| -46% | -$2.41M | 0.01% | 948 |
|
|
2021
Q4 | $5.91M | Buy |
33,900
+3,200
| +10% | +$533K | 0.01% | 769 |
|
|
2021
Q3 | $5.08M | Buy |
30,700
+10,800
| +54% | +$1.86M | 0.01% | 850 |
|
|
2021
Q2 | $3.58M | Buy |
19,900
+7,300
| +58% | +$1.33M | 0.01% | 824 |
|
|
2021
Q1 | $2.43M | Buy |
12,600
+5,600
| +80% | +$1.08M | 0.01% | 865 |
|
|
2020
Q4 | $1.41M | Sell |
7,000
-3,900
| -36% | -$807K | ﹤0.01% | 973 |
|
|
2020
Q3 | $2.29M | Buy |
10,900
+3,000
| +38% | +$668K | 0.01% | 758 |
|
|
2020
Q2 | $1.73M | Buy |
7,900
+2,900
| +58% | +$579K | 0.01% | 759 |
|
|
2020
Q1 | $866K | Sell |
5,000
-10,000
| -67% | -$1.65M | 0.01% | 754 |
|
|
2019
Q4 | $2.3M | Buy |
15,000
+4,100
| +38% | +$613K | 0.01% | 798 |
|
|
2019
Q3 | $1.66M | Buy |
10,900
+2,200
| +25% | +$348K | 0.01% | 781 |
|
|
2019
Q2 | $1.33M | Buy |
8,700
+1,200
| +16% | +$183K | 0.01% | 856 |
|
|
2019
Q1 | $1.2M | Buy |
7,500
+4,900
| +188% | +$760K | 0.01% | 752 |
|
|
2018
Q4 | $401K | Buy |
+2,600
| New | +$405K | 0.01% | 868 |
|
Other funds holding CLX
Capstone Investment Advisors's CLX Position: Q4 2024 in Review
Capstone Investment Advisors sold out of Clorox (CLX) in Q4 2024, closing a stake of 5,460 shares — an estimated $893K sold.
Capstone Investment Advisors first reported a position in CLX in Q3 2016 and held it in 20 quarters. The position peaked at $6.25M in Q3 2021. 1,225 funds tracked by Wall St. Rank hold CLX as of Q4 2024.
- Capstone Investment Advisors reported no remaining Clorox position as of Q4 2024 after selling out during the quarter.
- Capstone Investment Advisors sold 5,460 Clorox shares in Q4 2024, an estimated $893K.
- Capstone Investment Advisors first reported a position in Clorox in Q3 2016 and held it in 20 quarters.
- Capstone Investment Advisors's Clorox position peaked at $6.25M in Q3 2021.
- 1,225 funds tracked by Wall St. Rank held Clorox as of Q4 2024.
Based on Capstone Investment Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.